NCT02099266View on ClinicalTrials.gov

Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

February 29, 2016

Conditions
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome (MDS)Hodgkins LymphomaNon-Hodgkins Lymphoma
Interventions
DEVICE

Administration of hyperbaric oxygen

Hyperbaric oxygen at 2.5 atmospheres absolute (ATA) for a total of 2 hours

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER

NCT02099266 - Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment | Biotech Hunter | Biotech Hunter